Esther M John1,2,3,4, Meera Sangaramoorthy5, Jocelyn Koo5,6, Alice S Whittemore7,8, Dee W West5,6,7. 1. Cancer Prevention Institute of California, Fremont, CA, 94358, USA. emjohn@stanford.edu. 2. Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, 94304, USA. emjohn@stanford.edu. 3. Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, 94304, USA. emjohn@stanford.edu. 4. Stanford Cancer Institute, 780 Welch Road, Suite CJ250C, Stanford, CA, 94304-5769, USA. emjohn@stanford.edu. 5. Cancer Prevention Institute of California, Fremont, CA, 94358, USA. 6. Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, 94304, USA. 7. Department of Health Research and Policy, Stanford University of School of Medicine, Stanford, CA, 94305, USA. 8. Department of Biomedical Data Science, Stanford University of School of Medicine, 94305, Stanford, CA, USA.
Abstract
PURPOSE: Racial/ethnic minorities are often assumed to be less willing to participate in and provide biospecimens for biomedical research. We examined racial/ethnic differences in enrollment of women with breast cancer (probands) and their first-degree relatives in the Northern California site of the Breast Cancer Family Registry from 1996 to 2011. METHODS: We evaluated participation in several study components, including biospecimen collection, for probands and relatives by race/ethnicity, cancer history, and other factors. RESULTS: Of 4,780 eligible probands, 76% enrolled in the family registry by completing the family history and risk factor questionnaires and 68% also provided a blood or mouthwash sample. Enrollment was highest (81%) for non-Hispanic whites (NHWs) and intermediate (73-76%) for Hispanics, African Americans, and all Asian American subgroups, except Filipina women (66%). Of 4,279 eligible relatives, 77% enrolled in the family registry, and 65% also provided a biospecimen sample. Enrollment was highest for NHWs (87%) and lowest for Chinese (68%) and Filipinas (67%). Among those enrolled, biospecimen collection rates were similar for NHW, Hispanic, and African American women, both for probands (92-95%) and relatives (82-87%), but lower for some Asian-American subgroups (probands: 72-88%; relatives: 71-88%), foreign-born Asian Americans, and probands those who were more recent immigrants or had low English language proficiency. CONCLUSIONS: These results show that racial/ethnic minority populations are willing to provide biospecimen samples for research, although some Asian American subgroups in particular may need more directed recruitment methods. To address long-standing and well-documented cancer health disparities, minority populations need equal opportunities to contribute to biomedical research.
PURPOSE: Racial/ethnic minorities are often assumed to be less willing to participate in and provide biospecimens for biomedical research. We examined racial/ethnic differences in enrollment of women with breast cancer (probands) and their first-degree relatives in the Northern California site of the Breast Cancer Family Registry from 1996 to 2011. METHODS: We evaluated participation in several study components, including biospecimen collection, for probands and relatives by race/ethnicity, cancer history, and other factors. RESULTS: Of 4,780 eligible probands, 76% enrolled in the family registry by completing the family history and risk factor questionnaires and 68% also provided a blood or mouthwash sample. Enrollment was highest (81%) for non-Hispanic whites (NHWs) and intermediate (73-76%) for Hispanics, African Americans, and all Asian American subgroups, except Filipina women (66%). Of 4,279 eligible relatives, 77% enrolled in the family registry, and 65% also provided a biospecimen sample. Enrollment was highest for NHWs (87%) and lowest for Chinese (68%) and Filipinas (67%). Among those enrolled, biospecimen collection rates were similar for NHW, Hispanic, and African American women, both for probands (92-95%) and relatives (82-87%), but lower for some Asian-American subgroups (probands: 72-88%; relatives: 71-88%), foreign-born Asian Americans, and probands those who were more recent immigrants or had low English language proficiency. CONCLUSIONS: These results show that racial/ethnic minority populations are willing to provide biospecimen samples for research, although some Asian American subgroups in particular may need more directed recruitment methods. To address long-standing and well-documented cancer health disparities, minority populations need equal opportunities to contribute to biomedical research.
Entities:
Keywords:
African Americans; Asian Americans; Biospecimen collection; Breast cancer; Epidemiology; Hispanics; Race/ethnicity; Study participation
Authors: A R Giuliano; N Mokuau; C Hughes; G Tortolero-Luna; B Risendal; T E Prewitt; W J McCaskill-Stevens Journal: Ann Epidemiol Date: 2000-11 Impact factor: 3.797
Authors: David Wendler; Raynard Kington; Jennifer Madans; Gretchen Van Wye; Heidi Christ-Schmidt; Laura A Pratt; Otis W Brawley; Cary P Gross; Ezekiel Emanuel Journal: PLoS Med Date: 2005-12-06 Impact factor: 11.069
Authors: Esther M John; John L Hopper; Jeanne C Beck; Julia A Knight; Susan L Neuhausen; Ruby T Senie; Argyrios Ziogas; Irene L Andrulis; Hoda Anton-Culver; Norman Boyd; Saundra S Buys; Mary B Daly; Frances P O'Malley; Regina M Santella; Melissa C Southey; Vickie L Venne; Deon J Venter; Dee W West; Alice S Whittemore; Daniela Seminara Journal: Breast Cancer Res Date: 2004-05-19 Impact factor: 6.466
Authors: Cathy Samayoa; Jasmine Santoyo-Olsson; Cristian Escalera; Anita L Stewart; Carmen Ortiz; Leticia Márquez-Magaña; Aday Urias; Nayeli Gonzalez; Silvia A Cervantes; Alma Torres-Nguyen; Lorenia Parada-Ampudia; Anna M Nápoles Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-03 Impact factor: 4.254
Authors: Esther M John; Alison J Canchola; Meera Sangaramoorthy; Jocelyn Koo; Alice S Whittemore; Dee W West Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-09-05 Impact factor: 4.254
Authors: Esther M John; Theresa H Keegan; Mary Beth Terry; Jocelyn Koo; Sue A Ingles; Jenny T Nguyen; Catherine Thomsen; Regina M Santella; Khue Nguyen; Beizhan Yan Journal: Epidemiology Date: 2022-07-27 Impact factor: 4.860
Authors: Elisa V Bandera; Kitaw Demissie; Bo Qin; Adana A M Llanos; Yong Lin; Baichen Xu; Karen Pawlish; Jesse J Plascak; Jennifer Tsui; Angela R Omilian; William McCann; Song Yao; Christine B Ambrosone; Chi-Chen Hong Journal: J Cancer Surviv Date: 2020-01-06 Impact factor: 4.442
Authors: Julie R Palmer; Eric C Polley; Chunling Hu; Esther M John; Christopher Haiman; Steven N Hart; Mia Gaudet; Tuya Pal; Hoda Anton-Culver; Amy Trentham-Dietz; Leslie Bernstein; Christine B Ambrosone; Elisa V Bandera; Kimberly A Bertrand; Traci N Bethea; Chi Gao; Rohan D Gnanaolivu; Hongyan Huang; Kun Y Lee; Loic LeMarchand; Jie Na; Dale P Sandler; Payal D Shah; Siddhartha Yadav; William Yang; Jeffrey N Weitzel; Susan M Domchek; David E Goldgar; Katherine L Nathanson; Peter Kraft; Song Yao; Fergus J Couch Journal: J Natl Cancer Inst Date: 2020-12-14 Impact factor: 13.506
Authors: Esther M John; Valerie McGuire; Allison W Kurian; Jocelyn Koo; Salma Shariff-Marco; Scarlett Lin Gomez; Iona Cheng; Theresa H M Keegan; Marilyn L Kwan; Leslie Bernstein; Cheryl Vigen; Anna H Wu Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-12-18 Impact factor: 4.090
Authors: Lisa Gallicchio; Joanne W Elena; Sarah Fagan; Marjorie Carter; Ann S Hamilton; Theresa A Hastert; Lisa L Hunter; Jie Li; Charles F Lynch; Joel Milam; Morgan M Millar; Denise Modjeski; Lisa E Paddock; Amanda R Reed; Lisa B Moses; Antoinette M Stroup; Carol Sweeney; Edward J Trapido; Michele M West; Xiao-Cheng Wu; Kathy J Helzlsouer Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-07-10 Impact factor: 4.254